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1. Introduction 
Atrial redirection surgery, brought into common use by Mustard’s modification of the Senning 
procedure, transformed the natural history of dextro-transposition of the great arteries (d-
TGA) from a 90% one year mortality to a 90% 1 year survival(1). Although rendering the infant 
acyanotic with excellent functional capacity, the morphological right ventricle(sRV) is required 
to support the systemic circulation. The sRV faces substantial pressure overload resulting in a 
high incidence of late ventricular failure(2). This prompted an evolution to a more 
physiologically acceptable correction in the form of the arterial switch or Jatene operation(3). 
The arrhythmias and heart failure that usually manifest by the second decade of life in patients 
after atrial redirection surgery pose a challenge to management.  
Apart from the progressive sRV dysfunction and heart failure, sinus bradycardia commonly 
arises because of surgical disruption to the sino-atrial node blood supply warranting early 
pacemaker implantation (4). The incidence of tachyarrythmias, most notably atrial flutter and 
fibrillation, may be related to ventricular dysfunction or as a consequence of atrial scarring 
following surgery. Ventricular tachycardia (VT) and fibrillation (VF) have been documented 
on holter monitoring in various long term studies and the incidence of sudden cardiac death 
(SCD) ranges between 2-11%(5). Cardiac resynchronization with a biventricular implantable 
cardioverter-defibrillator (ICD) therefore poses an attractive option particularly as a bridge to 
transplantation in this group of patients. We examine the challenges in terms of the anatomical 
constraints in a group of consecutive patients with surgically corrected TGA(6;7). 
1.1 Relevant anatomical issues 
Placement of intracardiac leads may compromise the haemodynamic status of the patient. 
Mechanical obstruction from an intra-baffle stenosis or thrombotic obstruction may be 
encountered or concomitant known associations such as severe tricuspid regurgitation, valvar 
and sub-valvar pulmonary stenosis must be borne in mind.  
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Intra-baffle leaks raise the possibility of systemic embolization and inadvertent lead 
positioning within the sRV.  
The coronary sinus (CS) in d-TGA, as in the normal human heart, lies in the atrio-ventricular 
groove between the left atrium and sub-pulmonic left ventricle (pLV). In the case of 
surgically altered d-TGA, the resultant sRV, is therefore not encircled by the CS. This limits 
transvenous access to the lateral wall of the sRV, for lead placement. A large aberrant 
coronary vein arising from the sRV may drain into the CS or directly into the right atrium 
(RA) figure 1. This may present an option for lead placement. An anterolateral cardiac vein 
may be regarded as a poor pacing site for a failing systemic LV but may be entirely suitable 
for pacing the sRV. In an anatomical study by Uemura et al, in hearts with congenitally 
corrected transposition (atrio-ventricular and ventriculo-arterial discordance), the CS 
drained the sRV in the majority (87%) of specimens with 5 having partial or complete 
drainage directly into the atrium (8).  
Electrical stimulation of the failing systemic ventricle is usually achieved transvenously via CS 
cannulation, utilising specially designed left venticular pacing leads. If this is unsuccessful (eg. 
lack of a suitable ventricular vein) a trans-sternal, surgical approach may be used. The latter, 
however, may be preferable if conducted at the time of cardiac surgery or with surgically or 
congenitally altered anatomy that makes transvenous CS access difficult or unachievable. 
Access to the coronary venous vasculature post Mustard surgery in d-TGA is also 
dependent on whether the surgeon leaves the CS os open to the systemic-atrial side of the 
baffle or to the pulmonary-venous portion. The next challenge is percutaneous cannulation 
of the CS given the altered atrial structure. Pre-procedural imaging using cardiac magnetic 
resonance, computerized tomography, intracardiac or transoesophageal echocardiograpy 
improves identification of coronary venous anatomy (9-11).  
 
 
Fig. 1. The anticipated coronary venous structure in dTGA.  
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1.2 Evolving concepts of cardiac resynchronization therapy 
Cardiac resychronization therapy (CRT) has become an integral part of the management of 
patients with ischaemic and non-ischaemic cardiomyopathies presenting with advanced 
heart failure. This device based strategy has also been successfully applied in patients with 
adult congenital heart disease and ventricular dysfunction (12).  
Cardiac asynchrony has been traditionally defined in patients in terms of electrical (QRS 
width >120ms) and doppler echocardiography (conventional/ tissue doppler). The CRT 
non-responder population however remains between 20-30% warranting evaluation of 
additional or alternative measurements. Experience is however limited in patients with 
morphological sRVs and these selection criteria may not be relevant in this peculiar 
population (13;14;15). 
1.3 Patients 
All patients were derived from a a jointly managed group of patients at a tertiary referral 
centre for clinical electrophysiology and adult congenital heart disease. All patients had 
NYHA grade II-III heart failure symptoms with a perceived risk of SCD. Conventional 
management would have entailed inevitable cardiac transplantation, with its associated 
complications. The decision to resort to device therapy was therefore taken out of clinical 
and life-saving necessity and was conducted in terms of our current understanding of best 
clinical practice. Where innovative strategies were employed, this was used primarily to 
increase patient benefit from a more refined and patient specific technique. 
1.4 Statistical analysis 
Demographic data and simple statistical analysis was performed using SPSS and represented 
at mean±std dev. Where relevant a test of significance was performed using a t-test. 
2. Application of cardiac defibrillator therapy for at risk patients with failing 
systemic right ventricles 
Technical considerations implant details, and follow-up on 5 patients with d-TGA and a 
Mustard procedure receiving an ICD ± concomitant CRT are addressed below. Right 
ventricular function was assessed by a combining echocardiographic visual appraisal and 
planimetry as well as RV angiography. An individualized approach to implantation was 
undertaken, taking into consideration existing transvenous electrodes and post surgical 
cardiac anatomy. After implantation, patients were followed-up at 4-6 weeks and then 6-
monthly intervals. Data at follow-up including functional assessment, device interrogation, 
ECG and transthoracic echocardiograms (TTEs) were reviewed.  
The baseline characteristics of the 5 patients (4 male, age 18-35 years) studied are shown in 
table 1. All had significantly impaired sRV function (mean sRV EF=30%) and impaired 
functional class (NYHA class II-III). Two patients had sustained VT, 3 non-sustained VT, 
and 4 had atrial arrhythmias. Four patients had previously implanted pacemakers. Pre-
implant electrophysiological studies were not performed. 
2.1 Implant considerations 
Implanting a transvenous electrode into the pLV requires that the lead navigates through 
the surgical baffle. Baffle stenosis impeding flow from the superior vena cava (SVC) to the 
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pLV is common post Mustard modification(1). Defibrillator electrode placement will 
potentially further impede venous drainage and pLV filling. A strategic decision was 
therefore made not to implant multiple leads via anatomically narrow baffles and to treat 
any baffle stenosis prior to the implant. An entirely transthoracic defibrillation strategy was 
therefore employed in the first patient using a high energy defibrillator (maximum output of 
41J) with subcutaneous, single finger arrays (Model 6996. 25cm coil, 500cm2 surface. 
Medtronic, USA). Despite this defibrillation was ineffective figure 2.  
 
 
*NSVT=non sustained ventricular tachycardia, †SVT=supra-ventricular tachycardia, ‡VT=ventricular 
tachycardia 
Table 1. Salient baseline clinical characteristics of patients receiving defibrillators. 
Of the 4 patients with pre-existing pacemakers, 2 were demonstrated to have functional 
baffle stenosis and therefore underwent lead extraction and stent angioplasty at separate 
procedures at least 48 hours prior to transvenous insertion of a defibrillator lead. Those 
patients who had lead extractions and the patient with no pre-existing pacemaker 
underwent standard transvenous implantation with endocardial defibrillator coils placed 
via the subclavian vein into the pLV. Two patients with existing pacemakers and no 
evidence of baffle stenosis on cardiac catheterisation had their existing endocardial (pLV)  
 
  Patient 1 Patient 2 Patient 3 Patient 4 
 
Patient 5 
Age (years) at 
implantation 
24 22 35 18 25 
Documented 
arrhythmias 
Sinus 
bradycardia, 
atrial flutter, 
*NSVT 
Sinus 
bradycardia, 
‡
VT, 
*NSVT 
Sinus 
bradycardia,  
atrial flutter, 
*NSVT 
†
SVT, 
*NSVT 
Sinus 
bradycardia, 
†
SVT, 
*NSVT, 
‡
VT 
RVEF (%) 25 25 30 35 35 
Pre-existing 
device 
Yes Yes Yes No Yes 
Weight (kg) 110.2 106.1 77 67.4 54 
Implant Surgical Surgical Transvenous Transvenous Transvenous 
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Fig. 2. Diagrammatic view of the placement of the subcutaneous arrays (arrowed) around 
the chest wall in patient 1 with a sensing lead in the pLV. 
pace/sense electrodes conserved; 1 then had epicardial patch electrodes and 1 had 
subcutaneous arrays implanted at the time of trans-sternal, epicardial pacing lead placement 
for CRT. 
2.2 Defibrillation circuits and testing 
The patient with subcutaneous arrays, had the electrodes placed in an antero-posterior 
configuration around the left chest wall with a left sub-pectoral Can implantation (figure2).  
Ventricular fibrillation was induced via the chronic pLV endocardial pace/sense lead and 
therapies were delivered between the anterior and posterior subcutaneous arrays. A series 
of 6 inductions were performed with therapies of 25 to 41J but none were successful in 
terminating VF and external rescue shocks were required. Inclusion of the active Can in the 
circuit did not improve defibrillation outcome. 
One patient underwent epicardial patch electrode placement in the anterolateral and 
inferior positions over the systemic ventricle. This strategy was successful in defibrillating 
VF at 25J on the first induction (a 10J safety margin).  
The remaining 3 patients underwent standard transvenous system implants. An active Can 
was placed in the left sub-pectoral region and a defibrillation coil advanced under 
fluoroscopy to the pLV via the subclavian vein. The first 2 transvenous implants received 
dual coil leads (as is our standard practice when high DFTs are anticipated) but both had 
failed initial defibrillation, requiring exclusion of the SVC coil from the circuit. In 1 of these 
patients, a pLV to Can vector provided effective defibrillation at 25J, and in the other it was 
also necessary to reverse the polarity of the circuit to achieve this safety margin. This patient 
underwent 4 VF inductions and subsequently developed pulmonary oedema during the 
procedure.  
2.3 Follow up 
The median follow-up in all 5 patients was 20 months (range 15-24). A total of 4083 non-
sustained tachycardias were documented in the cohort over this period. One patient has 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Anterior Posterior
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had VT with pre-syncope which was correctly diagnosed and treated by a discharge by 
the ICD.  
2.4 Discussion 
Mustard patients are at increased risk of SCD defined by sRV dysfunction, heart failure 
functional status, non-sustained VT and atrial arrhythmias (5). Only 1 patient in the cohort 
had a preceding out-of-hospital arrest but all patients had documented multiple ventricular 
ectopics on 24-hour holter analysis. None of the patients received formal 
electrophysiological studies as we felt that a negative study should not disqualify them. The 
patients were < 40 years of age and lived productive lives up to the point of referral. The 
absence of therapies in the majority of the patients (4/5) over 2 years of follow-up does not 
mean that the decision to implant them was incorrect. The time to the first appropriate 
therapy in other patient groups with ICDs often exceeds 2 years (16). 
It has also not previously been demonstrated that the gold standard treatment for 
prevention of SCD, namely ICDs, are effective in this population, and given the variation 
from normal anatomy, efficacy should not be assumed. Appropriate vectors of defibrillation, 
as determined by electrode placement, are the key determinants of defibrillation success 
(17). The SVC cavity to pLV vector in particular appears to exclude much of the sRV and 
septum figure 3 whilst severe chamber dilatation, common in Mustard patients, is 
recognised from other populations to be associated with less effective defibrillation (18).  
 
 
Fig. 3. Electrode positions and defibrillation pathways of a dual coil lead system in a patient 
post Mustard correction. A dual coil defibrillator lead implanted into the pLV tends to be 
located more superiorly than when it is in an apical position in the right ventricle. The result 
is that the proximal electrode rests within the SVC/left subclavian vein. The defibrillation 
vector between the SVC and pLV thus excludes the major myocardial mass, reducing 
defibrillation efficacy. 
The role of polarity reversal is less well established. Data from randomised trials provides 
some evidence but no rational explanation, that by inverting vectors, efficacy may be 
improved in patients (19). However, with a limited number of inductions in any given 
individual, apparent differences in efficacy may be no more than a reflection of the 
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probabilistic nature of defibrillation success and we need to be cautious in making finite 
decisions as regards what will and will not work in individual patients. 
The single patient experience with subcutaneous defibrillation was plainly suboptimal with 
no successful defibrillation achieved. This may be a reflection of the Mustard anatomy or 
other independent factors that potentially may affect defibrillation efficacy. This patient had 
a body mass index of 33 and gross cardiomegaly. 
Our experience demonstrates that transvenous implantation is feasible but may require 
interventions such as lead extraction and angioplasty of the atrial baffle to avoid venous 
pathway obstruction. The optimal defibrillation vector with a transvenous implant appears 
to be pLV to active Can and as such, single coil leads are preferred. Our experience with 
subcutaneous arrays alone was unsatisfactory. Efficacy may be improved by selecting 
patients with a smaller body habitus and by incorporating intra-thoracic electrodes. 
Epicardial patches require an open chest procedure and may be placed at the time of 
concomitant epicardial CRT if indicated in the individual patient.  
The findings mandate the use of high output devices, regardless of the configuration, in 
anticipation of compromised defibrillation efficacy in similar patients which ultimately may 
prove more cost effective than undertaking revision procedures. 
2.5 Conclusion 
Defibrillator implantation in Mustard patients is feasible though challenging. Clinicians 
planning to implant such patients must be prepared to optimise the systemic venous access 
of the baffle prior to implantation and then to have strategies in place to tackle high 
defibrillation thresholds and the decompensation that may result from multiple VF 
inductions. Endocardial pLV to active Can and epicardial patches are effective defibrillation 
strategies in this group.  
3. Cardiac resynchronisation therapy 
Although the atrial switch was abandoned in the 1980s for the Jatene (arterial switch) 
procedure, a considerable number of patients have survived into their third decade of life 
(20). The right ventricle is not capable of supporting the systemic circulation for this 
extended period. Patients post Senning or Mustard operations, invariably experience right 
ventricular failure by the second and third decades of life (4;21). If cardiac transplantation is 
their only option, these patients face a post operative average life expectancy of just 10 years 
(22). Coupled with the limited availability of donors, this management plan is suboptimal 
for these, generally young patients. We present here 3 consecutive cases who had pre-
existing dual chamber pacemakers upgraded to CRT/D. Two required a hybrid approach 
using epicardial leads implanted by surgical thoracotomy while a 3rd successfully had an 
endocardial sRV pace/sense lead implanted. Although the results varied for these cases, 
they demonstrate plausible alternatives to management. 
3.1 Case presentations 
3.1.1 Case 1 
Patient 1 was 110 kg and 22 years old at time of implantation of his CRT/D system (table2). 
The underlying congenital anomaly of simple transposition was initially temporised by an 
atrial septostomy soon after birth and then with a Mustard operation at 7 months of age. At 
18 years of age he presented with sino-atrial node dysfunction (a common complication  
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  Patient 1  Patient 2  
Age (years) at implantation 22 24 
Wight (kg) 110 106 
Onset of symptoms 15 16 
Initial symptoms Effort intolerance Breathlessness & chest pain 
Gender M M 
NYHA III III 
Drug therapy    
ACE inhibitor Lisinopril Lisinopril 
Beta Blocker Bisoprolol Bisoprolol 
Cardiac glycoside Y Y 
Frusemide Y Y 
Spironolactone N Y 
Amiodarone Y N 
Echo features   
sRV  Dilated. Severely impaired Dilated, severely impaired 
pLV Moderately impaired “Normal” 
TR Mild Mild 
MR Trivial - 
ECG features   
BBB RBBB RBBB 
AVB First degree First degree 
QRS duration  120ms 160 ms 
CXR Cardiothoracic ratio 0.6 0.7 
SAN dysfunction Sinus bradycardia Sinus bradycardia 
NSVT Y Y 
VT N Y 
VF N N 
SVT Atrial Flutter (ablated) N 
*N-No   Y-Yes   mRV- morphological right ventricle   mLV- morphological left ventricle   TR-tricuspid 
regurgitation   MR-mitral regurgitation   BBB-Bundle branch block   AVB-atrioventricular block   SAN-
sino-atrial node   NSVT-non sustained VT   VT-ventricular tachycardia   VF-ventricular fibrillation   
SVT-supraventricular 
Table 2. Baseline clinical characteristics of 2 patients with Mustard corrections and 
prexisting pacemakers receiving an upgrade to CRT. 
following Mustard surgery) and therefore received a dual chamber pacemaker (Medtronic 
THERA DR 7968i. Medtronic. Inc., MA). Transthoracic echocardiogram revealed a dilated 
and myopathic sRV with an EF of 25% and a dp/dt ratio = 438.3 with evidence of 
asychronous ventricular contraction. The systemic ventricle (sRV) myocardial performance 
index was 0.53. An exercise treadmill test showed a suboptimal response with a cardiac 
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output of 3.9 l/min pre-exercise to 9.0 l/min at maximal exercise. He had an underlying 
right bundle branch block QRS morphology. Recent evidence from other series also suggest 
an increase risk of VT/VF and SCD in patients following Mustard procedures presenting 
with sRV dysfunction and atrial tachyarrhythmias (1). Cardiac resynchronization and 
defibrillator therapy offered a plausible alternative to delaying cardiac transplantation. The 
implant was performed via a mini-thoracotomy through the lower part of the previous 
sternal incision. The chronic atrial and pLV leads were conserved and a steroid eluting 
pace/sense electrode was sutured to the inferior epicardial surface of the right ventricle 
(Medtronic 4968). Two single-finger subcutaneous defibrillator arrays (Medtronic 6996) 
were implanted in an antero-posterior configuration and connected to the defibrillator ports 
of a Contak RENEWAL 4HE defibrillator (Guidant Inc.). Attempts at biventricular pacing 
(BVP) were also of limited benefit. A TTE guided optimization of CRT resulted in the sRV 
being paced 40ms before the pLV. The paced QRS remained predominantly right bundle 
branch block in morphology but had increased to 200ms from a baseline width of 120ms. 
Apart from not experiencing a subjective improvement in symptoms, the patient presented 
with episodes of recurrent paroxysmal atrial flutter documented on holter analysis. 
A successful flutter ablation was performed using non-contact mapping (EnsiteTM. St. Jude 
Medical). Two lines of block were created extending from the inferior vena cava to the 
inferior limb of the baffle and also from the tricuspid valve to the pulmonary venous side of 
the baffle. Despite further adjustment to the paced atrioventricular delay (AVD) and 
ventricular off-set, there was no improvement in symptoms. At his most recent follow-up 
doppler parameters suggested atrial pacing provided the optimal configuration (AAIR).  
His effort tolerance was quantified objectively on the treadmill using the Bruce protocol and 
he exercised for 6.58 minutes.  
3.1.2 Case 2 
The second patient (24 years) weighed 106kg, was born with simple d-TGA and a large 
patent ductus arteriosus which had spontaneously closed by the time of atrial baffle 
construction at 6 months of age. Thereafter periodic surveillance with TTE revealed a mild 
stenosis of the inferior limb of the atrial baffle. Onset of dyspnoea and effort related chest 
pain with diaphoresis occurred at 17 years and was assumed to be due to sRV dysfunction 
and demand ischaemia after demonstration of unobstructed coronary arteries. Like the 
previous patient, profound sinus bradycardia was documented on holter monitoring which 
resulted in pacemaker implantation at the age of 22. Two years later, his effort tolerance 
deteriorated from NYHA grade II to III/IV with an episode of VT and accompanying 
syncope. The decision was made to upgrade to a CRT/D. Preceding angiography 
demonstrated a stenosis in the inferior limb of the atrial baffle for which balloon angioplasty 
was successfully performed.  
The upgrade was performed by surgical thoracotomy, conserving the chronic atrial and 
ventricular pacing leads (Medtronic 5076). An epicardial steroid eluting electrode 
(Medtronic 4968) was attached to the inferior epicardial surface of the sRV. The pacing 
threshold of the sRV epicardial lead at implantation was 5.5v @ 0.5ms, with an R wave 
measuring 4.6mV and an impedance of 1100 ohms. The epicardial system showed a great 
variability in pacing parameters over a 9 month follow-up period post procedure (table3).  
Once again, the atrioventricular delay (AVD) and ventricular pacing off-set was guided by 
echocardiography and the sRV was paced 40ms ahead of the pLV in the final programming. 
The patient symptomatically improved to NYHA grade II status.  
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 sRV epicardial lead pLV endocardial lead RA endocardial lead 
 Threshold Resistance 
(ohms)
Threshold Resistance 
(ohms)
Threshold Resistance 
(ohms) 
Implant 0.5ms@5.5v 1100 0.2ms@1.5v 448 0.3ms@1.5v 480 
1 month* 0.5ms@6.0v 576 0.2ms@1.0v 432 0.4ms@1.0v 496 
6 month 0.3ms@5.0v 624 0.4ms@1.2v 464 0.4ms@1.0v 624 
9 month 0.3ms@5.0v 648 0.2ms@1.5v 448 0.3ms@1.5v 480 
* follow-up 
Table 3. Comparison of pacing parameters of epicardial and endocardial leads at sequential 
follow-up in patient 2 implanted post Mustard surgery with a hybrid CRT system. 
Cardiac resynchronization therapy has dramatically improved the quality of life in patients 
presenting with grade III and IV NYHA symptoms of heart failure (23). We have 
demonstrated here its application in two patients with sRV dysfunction using surgically 
positioned epicardial leads.  
It may be argued that preceding angioplasty of significant baffle related stenoses in both 
patients may have contributed to functional improvement. The baffle angioplasties were 
performed in both patients as a separate procedure at least 48 hours before device 
implantation. This was done primarily to reduce the duration of the device implantation 
procedure but neither patient demonstrated appreciable clinical or echocardiographic 
benefit from relief of the stenoses on myocardial function in the period leading up to the 
actual implant. 
The RV in a normal heart is a thinner walled and crescent shaped structure, that is not a 
suitable long term substitute for the left ventricle. The concave intrusion of the septum into 
the cavity of the RV also provides the optimal geometry for overall RV function (24). If left 
to chronically support the systemic circulation, the RV hypertrophies and dilates with 
subsequent flattening of the interventricular septum. The resultant dyskinetic septal motion 
further worsens the functional impairment of the dysfunctional RV. Resynchronization 
therapy should therefore serve not only to pace the RV free wall but co-ordinate this with 
septal motion. This complex anatomical and functional interaction suggests that we need to 
take greater care in positioning pacing leads over the sRV, to ensure adequate septal and 
free wall recruitment during biventricular pacing.  
From this discussion we can infer why CRT failed in the first patient. The epicardial lead 
was placed on the sRV at the discretion of the surgeon over its inferior border with no 
formal guidance. It was only limited by the pacing threshold at the respective site. This 
arbitrary placement may have been responsible for the non-response. Perhaps a more 
guided approach such as that suggested by Dekker et al using intra-procedural pressure-
volume loop monitoring may have altered the outcome (25).  
Epicardial pacing systems have been more frequently associated, than transvenous systems, 
with higher pacing thresholds, diaphragmatic stimulation, lead fracture and insulation 
breaks (26).The use of steroid eluting leads, does alleviate some of the deterioration in 
pacing parameters but this unfortunately did not offer an advantage in the second patient 
(27). Due to previous surgery, the location of viable myocardium for pacing is difficult and 
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placement of electrodes on the inferior aspect of both the sRVs was because of limited access 
to the sRV free wall. 
Transvenous attempts at coronary sinus cannulation may also result in failure to deliver a 
appropriately positioned lead. Mair et al in a comparative study, also demonstrated a higher 
complication rate with transvenous CS lead placement than with epicardial implantation via 
a mini-thoracotomy procedure (26). A video-assisted thoroscopy creating a minimally 
invasive percutaneous approach may be a solution but the option requires expertise and is 
dependent on centre availability (28). This prompted us to consider endocardial delivery of 
the pace/sense lead to the sRV in the next case study. 
The feasibility and safety of endocardial pacing of the systemic ventricle using a transseptal 
route to the left ventricle in normally “transposed” hearts was shown by Jais et al in a small 
series of 11 patients (29). In patients post Mustard correction, this would mean perforation 
through the atrial baffle or passage through a baffle leak to implant the lead onto the 
endocardial surface of the sRV followed by life long anticoagulation because of the potential 
for paradoxical and systemic embolization. Disruption to the atrial structures and 
interference with the atrioventricular valve may become issues in the long term follow-up of 
these patients but this remains an option with the benefit of more stable endocardial pacing 
thresholds. 
3.1.3 Case 3 
A 27 year old female with a Mustard procedure for d-TGA, and subsequent DDDR 
pacemaker implantation for sinus node dysfunction at age 17years, presented with 
progressive effort intolerance. Transthoracic echocardiogram and angiography revealed a 
dilated sRV with systolic dysfunction (EF=23%) and predominant lateral free wall 
hypokinesia.  
Holter monitoring revealed episodes of non-sustained ventricular tachycardia. The 12-lead 
electrocardiogram (ECG) revealed atrial and ventricular sequential pacing with fused 
sinus/paced QRS complexes measuring 130ms. She achieved just 4.8 minutes on treadmill 
testing (Bruce protocol) compared to just 8.4 minutes documented 10 years earlier. 
Preceding diagnostic cardiac catheterization revealed severe stenosis of the inferior baffle 
and a minor leak in the superior baffle communicating with the pulmonary venous atrium. 
Stent angioplasty of the inferior baffle was performed to relieve the obstruction (figure 4).  
A multi-electrode (MEA) catheter (Ensite 3000. St. Jude Medical. USA) was then inserted 
retrogradely across the aortic valve into the sRV and isopotential (voltage) maps were 
created of the sRV during AAI, DDD pacing (RA+pLV then RA+sRV). Biventricular 
pacing (BVP) was simulated by pacing from a roving ablation catheter (7F Stinger. Bard. 
Minneapolis.USA) within the sRV and by triggering sRV pacing after the sensed pLV 
impulse (figure 5). Because of this there was an inherent delay of 20ms after pLV chamber 
pacing. Atrial pacing (AAI) achieved diffuse and rapid activation of the sRV however 
Wenckebach’s phenomenon of the atrioventricular node was noted at just 70 beats per 
minute making constant ventricular pacing necessary. Voltage mapping during pLV 
apical pacing showed inhomogenous activation of the sRV in that the peak voltage 
activation waveform failed to involve considerable areas of the sRV free wall. Direct 
pacing of the endocardial surface of the sRV resulted in diffuse and rapid activation This 
was achieved from multiple sites on the sRV free-wall endocardium extending from the 
apex to the base. 
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Fig. 4. A. Shows the RA and pLV leads of the existing DDD pacemaker. Contrast injection 
into the IVC demonstrates a stenosis within the inferior baffle limb but was adequate to 
allow passage of the pigtail catheter. B. Shows the satisfactory post stent result. 
Baffle angioplasty and was initially performed thereafter a 4F lumenless pace/sense active 
fixation lead ( model 6996, SelectSecureTM. Medtronic Inc. ) was deployed using a steerable 
delivery sheath via a standard left subclavian vein approach with anticoagulation (heparin 
1000units/kg maintaining an activated clotting time of ± 300seconds). The superior limb of 
the systemic baffle was crossed through the baffle leak and positioned in the antero-basal 
segment of the sRV (figure 6).  
Instantaneous intra-arterial blood pressure response was assessed during AAI, DDD 
(RA+pLV and RA+sRV) and simulated biventricular pacing (BVP) (pLV+ sRV)(2). An 
arbitrary paced AVD of 110 ms was selected for DDD configurations (table 5). 
 
 
Stenosis within the 
inferior baffle limb
A 
Stented inferior 
baffle limb
B 
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Fig. 5. The MEA catheter is deployed in the sRV. Isopotential maps of the sRV are created 
from pacing off the RA & pLV leads and from a roving ablation catheter within the sRV. 
Despite the shortest activation time of 90ms occurring with AAI pacing, the maximal acute, 
blood pressure response of 73mmHg( average 60±9 mmHg) occurred during BVP 
(Table 5). An early (1week TTE) and sustained (after 6 months) 43% improvement in EF was 
also noted (23% to 33%). Effort tolerance improved from NYHA III to II accompanied by a 
decrease in QRS width from 130 to 120ms during consistent synchronous BVP in DDDR 
mode. No antitachycardia therapies have thus far been documented. 
 
 
Table 5. Tabulation of the maximal, acute, intra-procedural arterial blood pressure response 
obtained with each pacing modality. The AVD was arbitrarily set at 110ms.  
We have presented here a novel strategy using ventricular activation maps to direct 
endocardial lead placement in an effort to achieve successful BVP in patients with a Mustard 
procedure and a failing sRV. The application of CRT has been extrapolated to the adult 
congenital heart disease population following success in treating patients with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Pacemaker lead in pLV
Multi-electrode balloon 
catheter within the sRV
Roving catheter within 
sRV
Right atrial (RA) lead 
 Blood pressure response during pacing  
 Blood pressure (mmHg) Mean Blood pressure 
   
AAI 75/43 53 
DDD (RA/pLV)* 76/41 55 
DDD (RA/sRV)* 78/48 58 
BVP  (sRV+pLV) 100/58 73  
  60±9 mmHg 
*AVD=110 ms.  
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cardiomyopathies. Although no randomised controlled data exists for these patients, there 
has been documentation in the form of small case series (30). What is apparent is that 
conventional selection criteria may not apply and that there is variation in technical 
approaches sometimes requiring a combined endocardial and epicardial system.  
 
 
 
Fig. 6. A. Illustrates a small baffle leak in the superior limb allowing access for a sheath to 
deliver the 4F pacing lead into the sRV pictures in B. 
3.2 Conclusion 
The advent of atrial redirection surgery heralded potential survival to adulthood for 
patients with d-TGA who would have otherwise faced inevitable childhood death. 
However, the late complications arising from this surgery, particularly progressive heart 
failure and the increase risk of SCD remain challenges for management. The indications and 
best methods to effect successful CRT/D therapy however remain unknown apart from 
combined anecdotal evidence. In this patient cohort, we have demonstrated that the pLV to 
active defibrillator Can was the most successful as was the use of epicardial patches. An 
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exclusively transthoracic system utilizing subcutaneous electrodes proved unreliable 
because of the influence of weight in adult patients. A combination of intracardiac, intra-
thoracic and subcutaneous electrodes is however sometimes necessary to enhance 
defibrillation efficacy. 
The initial experience with CRT using a combined endocardial and epicardial lead system 
proved inconsistent and may have been because of poor patient selection but also because of 
suboptimal epicardial lead placement. The use of non contact mapping in addition to 
echocardiographic criteria was used to define asynchrony and guide endocardial placement 
of a pacing lead within the sRV. This warranted anticoagulation, but was performed with 
relative ease. 
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